首页> 美国卫生研究院文献>Journal of Orthopaedic Surgery and Research >Plasma D-dimer is not useful in the prediction of deep vein thrombosis after total knee arthroplasty in patients using rivaroxaban for thromboprophylaxis
【2h】

Plasma D-dimer is not useful in the prediction of deep vein thrombosis after total knee arthroplasty in patients using rivaroxaban for thromboprophylaxis

机译:在使用利伐沙班预防血栓形成的患者中血浆D-二聚体不能用于预测全膝关节置换术后的深静脉血栓形成

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundVenous thromboembolism (VTE) is a serious complication following total joint replacement. The use of rivaroxaban, a highly selective and direct factor Xa inhibitor, has been used widely as a safe and efficacious way to prevent VTE after total joint replacements. However, little is known about the diagnostic efficacy of plasma D-dimer test on deep vein thrombosis (DVT) in patients using rivaroxaban for thromboprophylaxis. The study is aimed to investigate the trend and the diagnostic efficacy of D-dimer test on DVT in patients with primary total knee arthroplasty (TKA) using rivaroxaban for thromboprophylaxis.
机译:背景静脉血栓栓塞症(VTE)是全关节置换术后的严重并发症。利伐沙班是一种高度选择性和直接的Xa抑制剂,已被广泛用作一种安全有效的方法,可在全关节置换后预防VTE。然而,对于使用利伐沙班预防血栓形成的患者的血浆D-二聚体试验对深静脉血栓形成(DVT)的诊断功效知之甚少。这项研究旨在探讨使用利伐沙班预防原发性全膝关节置换术(TKA)患者DVT二聚体试验对DVT的趋势和诊断功效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号